TY - JOUR
AR - JDMC-2020-1-107
TI - CAC: An Under-Utilized Tool for Screening of ASCVD in Diabetes
AU - Dharmendra , Panchal
AU - Sanjeev , Phatak
AU - Banshi , Saboo
AU - Rutul , Goklani
AU - Dhruvi , Hasnani
AU - Rikin , Shah
AU - Padmanabh , Zinzuwdia
JO - Journal of Diabetes Metabolism and its Complications
PY - 2020
DA - Wed 12, Aug 2020
SN - 2674-4163
DO - http://dx.doi.org/10.31487/j.JDMC.2020.01.07
UR - https://www.sciencerepository.org/cac-an-under-utilized-tool-for-screening-of-ascvd-in-diabetes_JDMC-2020-1-107 
KW - Cardiovascular disease, cardiovascular risk stratification, atherosclerotic cardiovascular disease, type 2 diabetes, coronary calcium score
AB - Diabetes Mellitus is the silent killer of the 21st century affecting 425 million people all over the world.
The situation is worse in south east Asia particularly India where the prevalence is increasing at a rapid
pace. The overall prevalence of diabetes in all 15 states of India was 7.3%. Coronary artery disease (CAD)
contributes the highest in morbidity, mortality and financial burden of diabetes. Observational studies
and RCTs report the prevalence of silent myocardial ischaemia in asymptomatic DM as 22%. There are
many ways to estimate cardiovascular risk in asymptomatic diabetes people like clinical risk score,
various biomarkers and other modalities like exercise stress test, echocardiography, Ankle Brachial Index
(ABI), Carotid Intima Media Thickness (CIMT), Coronary Artery Calcium Score (CAC), CT
angiography, Cardiac MRI, Nuclear Imaging etc. In this article we tried to review various modalities and
their usefulness in screening asymptomatic ASCVD. Out of all available modalities CAC score is found
to be very cost effectiveness and sensitive way to predict ASCVD. Still CAC is an underutilized modality
to screen asymptomatic ASCVD in diabetes people.